【Helius Medical Technologies-Product PoNS】Helius Announces Third Collaboration to Implement Clinical Experience Programs with PoNS? Treatment in the United States
3rd January 2019- Helius Medical Technologies, Inc. issued an announcement, which
is summarized as follows:
Helius Medical Technologies, Inc. announced that its wholly
owned subsidiary, NeuroHabilitation Corporation, entered into an agreement in
December 2018 to collaborate with Oregon Health & Science University (OHSU)
in Portland, Oregon for launch of its third Clinical Experience Program (CEP)
for PoNS?.
"Helius is excited to announce this important collaboration
with Oregon Health & Science University and we're pleased by the progress
that we made with respect to the development of our Clinical Experience Programs
– an important activity that we are pursuing in advance of U.S. regulatory
clearance," said Philippe Deschamps, Helius' Chief Executive Officer. "We look
forward to gaining more real-world experience in the clinical setting and
generate evidence demonstrating the health outcomes that can be achieved with
our innovative PoNS Treatment."
Mr. Deschamps continued: "We expect to begin patient
recruitment and enrollment at the OHSU Center for Regenerative Medicine in the
first quarter of 2019, following site activation and training."
The original website link:
https://heliusmedical.com/index.php/newsroom/news-release/2019/259-